Navigation Links
Mylan Launches First Generic Version of Vfend® Tablets
Date:2/15/2011

PITTSBURGH, Feb. 15, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole Tablets, 50 mg and 200 mg, under a previously announced settlement and license agreement with Pfizer Inc. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Voriconazole Tablets and was awarded 180 days of marketing exclusivity.  

Voriconazole Tablets are the generic version of Pfizer's Vfend® Tablets, a triazole antifungal agent. This product had U.S. sales of approximately $186 million for the 12 months ending Dec. 31, 2010, according to IMS Health.

Currently, Mylan has 170 ANDAs pending FDA approval representing $97.7 billion in annual sales, according to IMS Health. Forty-five of these pending ANDAs are potential first-to-file opportunities, representing $24.2 billion in annual brand sales, for the 12 months ending June 30, 2010, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
2. Mylans Matrix Obtains License for Promising HIV/AIDS Treatment
3. Mylan Announces Lipitor® Settlement Agreement
4. Mylan Announces Caduet® Settlement Agreement
5. Mylans Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
6. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg
7. Mylan Receives Approval for Generic Version of Precose® Tablets
8. Mylan Announces Voluntary De-listing of 1.25% Senior Convertible Notes Due 2012 from Nasdaq
9. Mylans Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe
10. Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT®
11. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
(Date:5/23/2013)... -- Amgen (NASDAQ: AMGN ) will present at ... Thursday, May 30, 2013, at the Westin Boston Waterfront Hotel, ... Daylight Time. Arvind Sood , vice president ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... ULURU Inc. (NYSE AMEX: ... development of a portfolio of wound management and oral ... for investment commitments with Ironridge Global BioPharma and its ... transactions, subject to certain conditions, to purchase common and ...
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that ... skin on the neck, on the brow and under the ... , Ultherapy is a non-surgical procedure for the face and ... lift the skin over time. The use of FDA-cleared ultrasound ... then treat the deepest support layers of the skin – ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Actos ... underway in U.S. District Court, Western District of Louisiana, ... According to a Case Management Order issued on May ... filing of contested motions in the Actos bladder cancer ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a ... and their inability to get adequate sleep. These same ... naturally relieve many symptoms. , Johns Hopkins University ... was significantly associated with overall weight loss, especially belly ... November 6th, 2012, researchers monitored 77 participants who were ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
(Date:5/25/2013)... 2013 Dr. Farooq Ashraf, founder of ... Dubai, has announced his practice’s adoption of The iFS ... FDA-cleared femtosecond laser proven with more than 10 years ... of LASIK. , “We are happy to announce that ... at our Dubai LASIK practice,” Ashraf said Thursday. “We ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2
... Oyster-related infections up, while Salmonella plateaus, says CDC report ... report a continuing decline in food-related illnesses caused by several ... , But Vibrio , a pathogen most often acquired ... is on the rise, while rates of Salmonella infection have ...
... says back disorders in the working population are among ... world. Disc degeneration is the main suspected origin of ... surgery. But Videman, a researcher in the University of ... common perception that disc degeneration is caused by physical ...
... Low levels of vitamin D are associated with lower lung ... to researchers at National Jewish Health. In a paper published ... Clinical Immunology, Daniel Searing, MD, and his colleagues also ... most effective controller medication for asthma. , "Asthmatic children in ...
... ... that Maureen Hanrahan has joined the company as a senior consultant specializing in managed ... SCHIP. , ... April 15, 2010 -- ArpegioHealth is pleased to announce that Maureen Hanrahan ...
... ... Workers’ Compensation claim for the amount of $34,000.00. , ... New Bedford, MA (PRWEB) April, 15, 2010 -- The law firm of Dussault and ... , ,The employee was injured while on the job while working as a truck-cleaner. The ...
... management of related condition leaves many undiagnosed, , THURSDAY, ... often fail to detect cases of chlamydia in young ... researchers contend. , They say that many urologists are ... known as epididymo-orchitis, which causes inflammation of the testicle ...
Cached Medicine News:Health News: E. coli Declines, but Other Foodborne Illnesses a Worry 2Health News: E. coli Declines, but Other Foodborne Illnesses a Worry 3Health News:Low vitamin D levels associated with more asthma symptoms and medication use 2Health News:Hanrahan Joins ArpegioHealth Consulting Firm 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: